Charcot-Marie-Yooth disease: A clinico-genetic confrontation

134Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder. It represents a group of clinically and genetically heterogeneous inherited neuropathies. Here, we review the results of molecular genetic investigations and the clinical and neurophysiological features of the different CMT subtypes. The products of genes associated with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity. Identifying the molecular basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiological mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system. The results of molecular genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients. © 2008 The Authors Journal compilation © 2008 University College London.

Cite

CITATION STYLE

APA

Barisic, N., Claeys, K. G., Sirotković-skerlev, M., Löfgren, A., Nelis, E., De Jonghe, P., & Timmerman, V. (2008, May). Charcot-Marie-Yooth disease: A clinico-genetic confrontation. Annals of Human Genetics. https://doi.org/10.1111/j.1469-1809.2007.00412.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free